IKENA ONCOLOGY INC's ticker is IKNA and the CUSIP is 45175G108. A total of 43 filers reported holding IKENA ONCOLOGY INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $8,008 | -34.0% | 1,849,513 | 0.0% | 0.34% | -8.8% |
Q2 2023 | $12,133 | +127.0% | 1,849,513 | +19.4% | 0.38% | +18.2% |
Q1 2023 | $5,346 | +29.7% | 1,549,513 | 0.0% | 0.32% | +38.3% |
Q4 2022 | $4,122 | -99.9% | 1,549,513 | 0.0% | 0.23% | -2.1% |
Q3 2022 | $5,501,000 | -19.9% | 1,549,513 | 0.0% | 0.24% | -36.0% |
Q2 2022 | $6,864,000 | -27.4% | 1,549,513 | 0.0% | 0.37% | -7.3% |
Q1 2022 | $9,452,000 | -51.4% | 1,549,513 | 0.0% | 0.40% | -24.9% |
Q4 2021 | $19,431,000 | -0.6% | 1,549,513 | 0.0% | 0.53% | +20.3% |
Q3 2021 | $19,555,000 | -10.1% | 1,549,513 | 0.0% | 0.44% | -0.9% |
Q2 2021 | $21,755,000 | -50.3% | 1,549,513 | 0.0% | 0.44% | -42.8% |
Q1 2021 | $43,774,000 | – | 1,549,513 | – | 0.77% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Atlas Venture Life Science Advisors, LLC | 5,018,178 | $62,928,000 | 5.78% |
Omega Fund Management, LLC | 2,249,123 | $28,204,000 | 3.99% |
CHI Advisors LLC | 814,756 | $10,217,000 | 3.39% |
BVF INC/IL | 1,798,371 | $22,552,000 | 0.82% |
Artal Group S.A. | 1,549,513 | $19,431,000 | 0.53% |
Orbimed Advisors | 2,933,941 | $36,792,000 | 0.47% |
Logos Global Management LP | 299,853 | $3,760,000 | 0.39% |
HealthCor Management, L.P. | 287,621 | $3,607,000 | 0.20% |
RA Capital Management | 750,000 | $9,405,000 | 0.17% |
FARALLON CAPITAL MANAGEMENT LLC | 1,081,309 | $13,560,000 | 0.07% |